Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
101.24 -1.05 / -1.03%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
101.23 -0.0121 / -0.01%
 
Volume: 20.5K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.8B

Company Description

Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1996 and is headquartered in Lexington, MA.

Contact Information

Synageva BioPharma Corp.
33 Hayden Avenue
Lexington Massachusetts 02421
P:(781) 357-9900
Investor Relations:
(781) 357-9947

Employees

Shareholders

Mutual fund holders60.27%
Other institutional46.74%
Individual stakeholders40.82%

Top Executives

Sanj K. PatelPresident, Chief Executive Officer & Director
Robert B. BazemoreChief Operating Officer
Carsten BoessChief Financial Officer & Senior Vice President
Anthony G. QuinnChief Medical Officer & Executive Vice President
Glen WilliamsSenior VP-Global Technical Operations & Quality

To view my watchlist

Not a member yet?

Sign up now for a free account